Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice.

Mol Ther

1] Department of Physical Therapy, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA [2] McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.

Published: April 2014

AI Article Synopsis

  • Pompe disease is caused by mutations in the GAA gene, leading to significant lingual dysfunction that doesn’t respond well to typical enzyme replacement therapy.
  • Research using Gaa(-/-) mice showed that an intralingual injection of adeno-associated virus (AAV) vectors encoding GAA effectively resulted in GAA expression and glycogen clearance in tongue muscles and hypoglossal motoneurons.
  • Among the tested vectors, AAV9 demonstrated greater efficacy than AAV1, resulting in more GAA-positive motoneurons and improved body weight gain.

Article Abstract

Pompe disease is an autosomal recessive disorder caused by mutations in the acid-α glucosidase (GAA) gene. Lingual dysfunction is prominent but does not respond to conventional enzyme replacement therapy (ERT). Using Pompe (Gaa(-/-)) mice, we tested the hypothesis that intralingual delivery of viral vectors encoding GAA results in GAA expression and glycogen clearance in both tongue myofibers and hypoglossal (XII) motoneurons. An intralingual injection of an adeno-associated virus (AAV) vector encoding GAA (serotypes 1 or 9; 1 × 10(11) vector genomes, CMV promoter) was performed in 2-month-old Gaa(-/-) mice, and tissues were harvested 4 months later. Both serotypes robustly transduced tongue myofibers with histological confirmation of GAA expression (immunochemistry) and glycogen clearance (Period acid-Schiff stain). Both vectors also led to medullary transgene expression. GAA-positive motoneurons did not show the histopathologic features which are typical in Pompe disease and animal models. Intralingual injection with the AAV9 vector resulted in approximately threefold more GAA-positive XII motoneurons (P < 0.02 versus AAV1); the AAV9 group also gained more body weight over the course of the study (P < 0.05 versus AAV1 and sham). We conclude that intralingual injection of AAV1 or AAV9 drives persistent GAA expression in tongue myofibers and motoneurons, but AAV9 may more effectively target motoneurons.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982493PMC
http://dx.doi.org/10.1038/mt.2013.282DOI Listing

Publication Analysis

Top Keywords

gaa expression
12
tongue myofibers
12
intralingual injection
12
pompe disease
8
gaa-/- mice
8
encoding gaa
8
glycogen clearance
8
xii motoneurons
8
versus aav1
8
aav1 aav9
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!